JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 29, 2003; DOI: 10.1124/jpet.103.050260


0022-3565/03/3062-744-751$20.00
JPET 306:744-751, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.050260v1
306/2/744    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, H.-L.
Right arrow Articles by Hollenberg, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, H.-L.
Right arrow Articles by Hollenberg, P. F.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Threonine-205 in the F Helix of P450 2B1 Contributes to Androgen 16{beta}-Hydroxylation Activity and Mechanism-Based Inactivation

Hsia-Lien Lin, Haoming Zhang, Lucy Waskell, and Paul F. Hollenberg

Department of Pharmacology, University of Michigan (H.L., P.F.H.), and Department of Anesthesiology, Veteran Affairs Health Service (H.Z., L.W.), Ann Arbor, Michigan

Four mutants of Thr-205 in cytochrome P450 2B1 were constructed and expressed in Escherichia coli. The Ser-, Ala-, and Val-mutants displayed stable reduced CO difference spectra and were able to metabolize 7-ethoxy-4-(trifluoromethyl)coumarin, testosterone, androstenedione, and benzphetamine. The Arg-mutant displayed an unstable reduced CO difference spectrum at 450 nm, was concomitantly converted to a denatured form with a peak at 422 nm, and showed no catalytic activity with any of the four substrates tested. The Ser-mutant displayed activity and metabolite profiles for testosterone and androstenedione similar to those of the wild-type P450 2B1 (WT). Substitution of Thr-205 with Ala or Val markedly suppressed the 16{beta}-hydroxylation activity but exhibited little effect on the 16{alpha}-hydroxylation activity for testosterone and androstenedione. Because 16{beta}-hydroxylation activity of androgens is a specific P450 2B subfamily marker and residue 205 is located in the F helix, which forms the ceiling of the active site, we postulate that the {gamma}-hydroxyl side chain of Thr may play an important role in directing the 16{beta}-face of testosterone and androstenedione toward the active site. Surprisingly, the Val-mutant retained full activity for benzphetamine demethylation. When mechanism-based inactivators for P450 2B1 were used to evaluate the susceptibility to inactivation, the Val-mutant was resistant to inactivation by 17{alpha}-ethynylestradiol and less sensitive to inactivation by 2-ethynylnaphthalene compared with the WT enzyme. Our results demonstrate the importance of Thr-205 in determining substrate specificity and product formation as well as in influencing the susceptibility of P450 2B1 to mechanism-based inactivators.


Received February 14, 2003; accepted April 16, 2003.

Address correspondence to: Dr. Paul F. Hollenberg, Department of Pharmacology, MSRB III, 1150 West Medical Center Dr., Ann Arbor, MI 48109-0632. E-mail: phollen{at}umich.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. K. Muralidhara, S. Negi, C. C. Chin, W. Braun, and J. R. Halpert
Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains: SOLUTION THERMODYNAMICS AND MOLECULAR MODELING
J. Biol. Chem., March 24, 2006; 281(12): 8051 - 8061.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-l. Lin, U. M. Kent, and P. F. Hollenberg
The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 154 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-L. Lin, U. M. Kent, H. Zhang, L. Waskell, and P. F. Hollenberg
The Functional Role of Threonine-205 in the Mechanism-Based Inactivation of P450 2B1 by Two Ethynyl Substrates: The Importance of the F Helix in Catalysis
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 855 - 863.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Scott, M. A. White, Y. A. He, E. F. Johnson, C. D. Stout, and J. R. Halpert
Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-A Resolution: INSIGHT INTO THE RANGE OF P450 CONFORMATIONS AND THE COORDINATION OF REDOX PARTNER BINDING
J. Biol. Chem., June 25, 2004; 279(26): 27294 - 27301.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.